A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases
Phase 2 Completed
108 enrolled 13 charts
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants
Phase 1 Completed
15 enrolled
VIOLETTE
Phase NA Completed
76 enrolled
MK-5684-001
Phase 1 Completed
14 enrolled
A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients
Completed
1,247 enrolled
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
Phase 1 Completed
10 enrolled
A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617
Completed
6,448 enrolled
ARANOTE
Phase 3 Completed
669 enrolled 16 charts
Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)
Phase 1/2 Completed
127 enrolled 16 charts
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Phase 2 Completed
131 enrolled 12 charts
Solar-Recur
Phase 3 Completed
235 enrolled
A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors
Phase 1 Completed
82 enrolled
Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate Cancer
Phase 1 Completed
24 enrolled 10 charts
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Completed
1,083 enrolled 29 charts
PROSPER
Phase 3 Completed
1,401 enrolled 25 charts
CheckMate 9KD
Phase 2 Completed
292 enrolled 21 charts
PRISME
Completed
831 enrolled
OncoACP-3
Phase 1 Completed
20 enrolled
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Completed
3,017 enrolled 5 charts
Galahad
Phase 2 Completed
289 enrolled 18 charts
CheckMate 650
Phase 2 Completed
351 enrolled 43 charts
Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 1 Completed
131 enrolled
BARVANA LONG
Completed
70 enrolled
Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer
Phase 2/3 Completed
57 enrolled 15 charts
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
Completed
979 enrolled
Description of Relugolix Use in Patients With Prostate Cancer Within the VHA
Completed
507 enrolled 13 charts
A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)
Completed
1,300 enrolled
QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA
Phase 1/2 Completed
43 enrolled 15 charts
An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants
Phase 3 Completed
395 enrolled 25 charts
A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.
Phase 1/2 Completed
98 enrolled
GuidePath
Phase 3 Completed
190 enrolled 25 charts
ARROW
Phase 2 Completed
120 enrolled 21 charts
Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients
Completed
1,018 enrolled
GuideView
Phase 2/3 Completed
195 enrolled 31 charts
Spotlight
Phase 3 Completed
391 enrolled 30 charts
BP-008
Completed
20 enrolled
CLP-10095
Completed
175 enrolled
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
Phase 4 Completed
55 enrolled
A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects
Phase 1 Completed
16 enrolled
Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate
Phase 3 Completed
195 enrolled 19 charts
IS-002 Phase 2 Prostate Cancer Study
Phase 2 Completed
59 enrolled
Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate
Phase 3 Completed
387 enrolled
OLAP
Completed
661 enrolled
A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely
Completed
13,779 enrolled
Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Phase 1 Completed
45 enrolled
TriptoSwitch
Phase 3 Completed
147 enrolled 14 charts
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Phase 1 Completed
23 enrolled
KEYNOTE-921
Phase 3 Completed
1,030 enrolled 24 charts
XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
Phase 2 Completed
72 enrolled
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
Phase 3 Completed
136 enrolled